GeneDx, a leading provider of genetic testing, has announced the appointment of Linda Genen as its new Chief Medical Officer (CMO). This strategic hire underscores GeneDx’s commitment to clinical leadership adn innovation in the field of genomic medicine.
ms. Genen brings a wealth of experience to GeneDx, having previously served as the Chief Medical Officer at ProgenyHealth. Her expertise in clinical operations, medical affairs, and healthcare strategy will be instrumental as GeneDx continues to expand its diagnostic capabilities and enhance patient care.
“We are thrilled to welcome Linda to the GeneDx team,” said a GeneDx spokesperson. “Her proven track record of success in leading medical teams and driving innovation makes her an ideal fit for our organization. We are confident that she will play a key role in advancing our mission to improve the lives of patients wiht genetic conditions.”
The appointment of a new CMO signals a period of growth and growth for GeneDx as it navigates the evolving landscape of genetic testing and personalized medicine. The company actively seeks qualified professionals to fill key roles, and encourages submissions of personnel changes for potential coverage.
Read more about industry moves at STAT+
Related reading